Abstract
The in vitro activity of CI-934, a new quinolone antimicrobial, was compared with that of ciprofloxacin against selected gram-positive bacteria. Concentrations of CI-934 required to inhibit 90% of strains (MIC90) were twofold to eightfold lower than those of ciprofloxacin. With the exception of Streptococcus faecium, all isolates were inhibited by CI-934 at concentrations ≤1.0 μg/ml.
Original language | English (US) |
---|---|
Pages (from-to) | 341-344 |
Number of pages | 4 |
Journal | Diagnostic Microbiology and Infectious Disease |
Volume | 5 |
Issue number | 4 |
DOIs | |
State | Published - Nov 1986 |
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
- Infectious Diseases